EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT

Ruowu Liu iD, Jiao Zhou, Jing Zhou iD, Feng Liu, Yafeng Liu, Juan Meng, Luo Ba, Hengyi Xiao, Shixi Liu, Nan Zhang, Claus Bachert, Jintao Du iD

International Forum of Allergy & Rhinology · 2025-08 · 15 (8) · 837-850

DOI: 10.1002/alr.23558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 25.03.2025. Verfasst von Ruowu Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: MicroRNAs, Mast Cells, Interleukin-33, Sinusitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Postdoctor Research Fund of West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mast cells (MCs) are involved in type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP), which depends on interleukin (IL)‐33 stimulation. MiR‐221 is reported to be an important regulator of MCs, and miR‐221‐3p can be expressed in CRSwNP. However, the role of miR‐221‐3p in CRSwNP is unclear.

Methods

Ethmoid tissues from control subjects ( n = 12) and polyps from patients with CRSwNP ( n = 40) were collected. The expression of miR‐221‐3p and cytokines was detected by real‐time quantitative polymerase chain reaction (qPCR). The activation of P65 and ERK was determined by western blotting. The localization of miR‐221‐3p was detected via in situ hybridization combined with immunofluorescence (IF), and its target was identified via a luciferase reporter system. Human MCs were incubated with IL‐33 or stem cell factor. MicroRNA mimics/inhibitor and lentiviral plasmids were used to determine the role of miR‐221‐3p in MCs.

Results

We observed increased expression of miR‐221‐3p in CRSwNP, and localized its expression in MCs. The expression of miR‐221‐3p was negatively correlated with that of IL‐4, IL‐5, and IL‐13 in CRSwNP. MiR‐221‐3p can be induced by IL‐33 in MCs and plays a negative regulatory role in cytokine expression and signaling pathways in IL‐33‐induced MC activation. As the direct target of miR‐221‐3p, the receptor KIT was negatively correlated with miR‐221‐3p and decreased in CRSwNP. In MCs, KIT is essential for an effective response to IL‐33 stimulation. We here demonstrated that miR‐221‐3p regulates cytokine expression by targeting KIT in IL‐33‐activated MCs.

Conclusions

MiR‐221‐3p inhibits MC‐dependent type 2 inflammatory conditions, rendering it a negative regulator of CRSwNP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMast CellsInterleukin-33SinusitisProto-Oncogene Proteins c-kitRhinitisNasal PolypsCytokinesHumansMaleFemaleAdultMiddle AgedCells, CulturedChronic Disease

Stichwörter der Autor:innen

CRSwNPIL‐33KITmast cellmiR‐221‐3p

Substanzen

MicroRNAsInterleukin-33Proto-Oncogene Proteins c-kitCytokinesMIR221, humanKIT protein, humanIL33 protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Medicine and Engineering Interdisciplinary Research Laboratory of Nursing & Materials, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Otolaryngology, People's Hospital of Tibet Autonomous Region, Lhasa, China.
  • Department of Aging and Geriatric Medicine, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Münster, Münster, Germany.

ORCID-Profile: Ruowu Liu, Jing Zhou, Jintao Du

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province
  • Postdoctor Research Fund of West China Hospital, Sichuan University

Zitieren

APA

Liu, R., Zhou, J., Zhou, J., Liu, F., Liu, Y., Meng, J., Ba, L., Xiao, H., Liu, S., Zhang, N., Bachert, C., & Du, J. (2025). MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT. International Forum of Allergy & Rhinology, 15(8), 837-850. https://doi.org/10.1002/alr.23558

Vancouver

Liu R, Zhou J, Zhou J, Liu F, Liu Y, Meng J, et al. MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT. International Forum of Allergy & Rhinology. 2025;15(8):837-850. doi:10.1002/alr.23558

BibTeX
@article{Liu2025,
  author = {Liu, Ruowu and Zhou, Jiao and Zhou, Jing and Liu, Feng and Liu, Yafeng and Meng, Juan and Ba, Luo and Xiao, Hengyi and Liu, Shixi and Zhang, Nan and Bachert, Claus and Du, Jintao},
  title = {MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT},
  journal = {International Forum of Allergy & Rhinology},
  year = {2025},
  volume = {15},
  number = {8},
  pages = {837--850},
  doi = {10.1002/alr.23558}
}
Kostenlos starten →